Your browser doesn't support javascript.
loading
An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.
Krishnananthasivam, Shivankari; Li, Hao; Bouzeyen, Rania; Shunmuganathan, Bhuvaneshwari; Purushotorman, Kiren; Liao, Xinlei; Du, Fengjiao; Friis, Claudia Guldager Kring; Crawshay-Williams, Felicity; Boon, Low Heng; Xinlei, Qian; Chan, Conrad En Zuo; Sobota, Radoslaw; Kozma, Mary; Barcelli, Valeria; Wang, Guirong; Huang, Hairong; Floto, Andreas; Bifani, Pablo; Javid, Babak; MacAry, Paul A.
Afiliación
  • Krishnananthasivam S; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Li H; College of Veterinary Medicine, China Agricultural University, Beijing, China.
  • Bouzeyen R; Center for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing, China.
  • Shunmuganathan B; Division of Experimental Medicine, University of California, San Francisco, USA.
  • Purushotorman K; Life Sciences Institute, National University of Singapore, Singapore, Singapore.
  • Liao X; Life Sciences Institute, National University of Singapore, Singapore, Singapore.
  • Du F; National Clinical Laboratory on Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing Chest Hospital, Capital Medical University, Beijing, P.R. China.
  • Friis CGK; National Clinical Laboratory on Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing Chest Hospital, Capital Medical University, Beijing, P.R. China.
  • Crawshay-Williams F; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Boon LH; Molecular Immunity Unit, University of Cambridge, Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Xinlei Q; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Chan CEZ; Life Sciences Institute, National University of Singapore, Singapore, Singapore.
  • Sobota R; National Centre for Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.
  • Kozma M; Defence Medical and Environmental Research Institute, DSO National Laboratories, Singapore, Singapore.
  • Barcelli V; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
  • Wang G; Life Sciences Institute, National University of Singapore, Singapore, Singapore.
  • Huang H; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Floto A; National Clinical Laboratory on Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing Chest Hospital, Capital Medical University, Beijing, P.R. China.
  • Bifani P; National Clinical Laboratory on Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing Chest Hospital, Capital Medical University, Beijing, P.R. China.
  • Javid B; Molecular Immunity Unit, University of Cambridge, Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • MacAry PA; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
NPJ Vaccines ; 8(1): 127, 2023 Aug 25.
Article en En | MEDLINE | ID: mdl-37626082
Tuberculosis (TB) is an airborne disease caused by Mycobacterium tuberculosis (Mtb). Whilst a functional role for humoral immunity in Mtb protection remains poorly defined, previous studies have suggested that antibodies can contribute towards host defense. Thus, identifying the critical components in the antibody repertoires from immune, chronically exposed, healthy individuals represents an approach for identifying new determinants for natural protection. In this study, we performed a thorough analysis of the IgG/IgA memory B cell repertoire from occupationally exposed, immune volunteers. We detail the identification and selection of a human monoclonal antibody that exhibits protective activity in vivo and show that it targets a virulence factor LpqH. Intriguingly, protection in both human ex vivo and murine challenge experiments was isotype dependent, with most robust protection being mediated via IgG2 and IgA. These data have important implications for our understanding of natural mucosal immunity for Mtb and highlight a new target for future vaccine development.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: NPJ Vaccines Año: 2023 Tipo del documento: Article País de afiliación: Singapur Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: NPJ Vaccines Año: 2023 Tipo del documento: Article País de afiliación: Singapur Pais de publicación: Reino Unido